PlainRecalls
FDA Drug Moderate Class II Terminated

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01

Reported: June 24, 2020 Initiated: June 11, 2020 #D-1308-2020

Product Description

Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01

Reason for Recall

Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

Details

Units Affected
82,426 vials
Distribution
Nationwide within the United States
Location
Cherry Hill, NJ

Frequently Asked Questions

What product was recalled?
Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01. Recalled by Hikma Pharmaceuticals USA Inc.. Units affected: 82,426 vials.
Why was this product recalled?
Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 24, 2020. Severity: Moderate. Recall number: D-1308-2020.